DAVION HEALTHCARE PLC

Davion Healthcare is a medical device company focused on developing home tests for a range of home test products designed to identify potential medical conditions and provide early warning to enable further clinical examination where applicable. Its mission is to afford early non-invasive detection of possible physical abnormalities including breast growths, testicular growths, blood flow and more. Davion Healthcare Plc was originally incorporated in Cyprus as a public limited company on November 29, 2022 and subsequently re-domiciled its company headquarters to Ireland in September 2024, maintaining an operation in Cyprus through its wholly owned subsidiary, Davion Healthcare Ltd. The company moved from Cyprus to Ireland within the European Union community, where it can more easily focus on developing its range of home tests. Davion Healthcare uses third party research and development (Universities and specialized companies) together with outsourced manufacturing and design, to make products, which are then patented (where applicable), manufactured, sold and internationally distributed through licensing agreements. The company operates under a licensing-based commercialization model pursuant to which it designs, develops, and patents medical products and non-diagnostic devices and then licenses the manufacturing, marketing, sales, and distribution rights for its products to regional or global commercial partners. These licensees are responsible for obtaining necessary regulatory approvals in their territories and for delivering product support, including customer service and warranty administration. Under the company's standard form of licensing agreement, the licensee is granted the right, on an exclusive or non-exclusive basis depending on the territory and product, to manufacture and/or distribute the licensed product within a defined geographic region. The company typically retains ownership of all intellectual property and grants the licensee a limited, revocable right to use the company's patents, trademarks, and proprietary know-how solely for the purpose of manufacturing and commercializing the licensed product in the agreed territory.